1-Week Dispensing Evaluation of REVIVE™ Toric Soft Contact Lenses

Refractive Ametropia Clinical Trial

Official title: 1-Week Dispensing Evaluation of REVIVE™ Toric Soft Contact Lenses

Status Completed

Clinical Trial Summary

Experienced soft contact lens wearing subjects will be enrolled in this 1-week, post-market, bilateral, repeated measures, dispensing study. All subjects will be seen for a Screening/Dispensing Visit at which informed consent will be obtained and eligibility will be assessed. If subjects satisfy all eligibility criteria and none of the exclusion criteria, subjects will be fit and dispensed study lenses. If unsuccessful in the dispensed lenses, additional lenses may be trialed. Once vision and lens fit are determined to be acceptable, eligible subjects will wear study lenses in both eyes for at least 8 hours per day (with the exception of the follow-up visits where the lenses should be worn for a minimum of 2 hours), for approximately 1 week (7 days +/-3 days). Measurements will be taken at the insertion visit and at the 7-day follow-up visit.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Refractive Ametropia
• Refractive Errors

• NCT number: NCT06053736
• Study type: Interventional
• Source: Bausch & Lomb Incorporated
• Status: Completed
• Phase: N/A
• Start date: October 4, 2023
• Completion date: December 15, 2023